Simonyan M. A, Shvartz V. A, Karavaev A. S, Skazkina V. V, Sokolskaya M. A, Borovkova E. I, Petrosyan A. D, Ishbulatov Y. M, Posnenkova O. M, Kiselev A. R. Features of Spectral Estimates of the Photoplethysmographic Waveform Variability in Patients ith Aortic Stenosis. Biomed Pharmacol J 2022;15(3).
Manuscript received on :24-10-2020
Manuscript accepted on :06-04-2022
Published online on: 22-07-2022
Plagiarism Check: Yes
Reviewed by: Dr. Daniel Penteado Martins Dias  
Second Review by: Dr. Sharad kamble
Final Approval by: Dr. H Fai Poon

How to Cite    |   Publication History
Views  Views: 
Visited 444 times, 1 visit(s) today
 
Downloads  PDF Downloads: 
355

Simonyan M. A.1, Shvartz V.A.2, Karavaev A. S.1,3,4, Skazkina V.V.2,4, Sokolskaya M. A.2, Borovkova E. I.1,4, Petrosyan A. D.2, Ishbulatov Yu. M.1,2, Posnenkova O.M.1 and Kiselev A. R.1,2,4

1Saratov State Medical University, Saratov, Russia

2Bakulev Scientific Center for Cardiovascular Surgery, Moscow, Russia

3Saratov Branch of the Institute of Radio Engineering and Electronics of Russian Academy of Sciences, Saratov, Russia

4Saratov State University, Saratov, Russia

Corresponding Author E-mail: kiselev@cardio-it.ru

DOI : https://dx.doi.org/10.13005/bpj/2459

Abstract

IntroductionA well-known method for assessing the autonomic status of patients in clinical practice is the use of spectral estimates of finger's photoplethysmographic waveform variability (PPGV). However, these estimates have not been studied in patients with aortic stenosis. Therefore, this study aimed to identify in the PPGV spectrum the markers of autonomic dysfunction specific for patients with aortic stenosis. MethodsThe study included 34 patients with aortic stenosis at the age of 54 (43, 67) years and 30 healthy subjects at the age of 34 (31, 36) years (data presented as median with lower and upper quartiles). The following spectral estimates of PPGV were evaluated: LF% (low-frequency band, 0.04–0.15 Hz, in the percentage of total spectral power, 0–0.4 Hz), HF% (high-frequency band, 0.15–0.4 Hz, in the percentage of total spectral power, 0–0.4 Hz), and LF/HF ratio. ResultsThe study revealed the statistically significant (p<0.05) differences in HF% and LF% values in patients with aortic valve disease compared with healthy people. LF% was increased by 2-4 times in group of patients with aortic stenosis, while HF% was increased by 1.2-7 times. The difference between the groups at LF/HF ratio was statistically insignificant. ConclusionPatients with aortic stenosis are characterized by higher LF% and HF% values, relative to healthy people of comparable age.

Keywords

Aortic Stenosis; Photoplethysmogram; Spectral Analysis

Download this article as: 
Copy the following to cite this article:

Simonyan M. A, Shvartz V. A, Karavaev A. S, Skazkina V. V, Sokolskaya M. A, Borovkova E. I, Petrosyan A. D, Ishbulatov Y. M, Posnenkova O. M, Kiselev A. R. Features of Spectral Estimates of the Photoplethysmographic Waveform Variability in Patients ith Aortic Stenosis. Biomed Pharmacol J 2022;15(3).

Copy the following to cite this URL:

Simonyan M. A, Shvartz V. A, Karavaev A. S, Skazkina V. V, Sokolskaya M. A, Borovkova E. I, Petrosyan A. D, Ishbulatov Y. M, Posnenkova O. M, Kiselev A. R. Features of Spectral Estimates of the Photoplethysmographic Waveform Variability in Patients ith Aortic Stenosis. Biomed Pharmacol J 2022;15(3). Available from: https://bit.ly/3PugHBl

Introduction

Currently, aortic valve failure makes 43% of all cases of lesions of the heart valve apparatus [1], with almost half of them being aortic stenosis [2]. The issue of early diagnosis of the disease in asymptomatic patients is quite acute due to the widespread prevalence of aortic valve pathology, prolonged asymptomatic course, high disability, and mortality [2, 3].

Earlier it was shown that destruction of autonomic control of the cardiovascular system is observed with the development of aortic valve failure (stenosis and/or cardiac decompensation) [4]. To date, there exist and are actively used methods for assessing the functioning of autonomic regulation, such as the analysis of heart rate variability (HRV) and the assessment of spectral parameters of photoplethysmographic waveform variability (PPGV) [5, 6]. Clinical practice includes the use of HRV estimates for assessing the risks of developing cardiovascular pathology [5, 7], sudden cardiac death [8], assessing the quality of patient treatment (including cardiac surgery) [9, 10], as well as predicting the risk of developing cardiovascular complications in patients with previous cardiac diseases [11-14]. We have previously described the features of autonomic regulation in men with arterial hypertension and ischemic heart disease using spectral analysis of PPGV in these groups of patients in comparison with healthy people [15]. In the course of the study, significant differences were revealed in the frequency components of the PPGV spectrum, which characterize the autonomic imbalance. Nevertheless, approaches to the diagnosis of autonomic dysfunction in patients with aortic valve defects, in particular, aortic stenosis, have not been adequately studied.

This study aimed to identify autonomic dysfunction markers in the PPGV spectrum that are specific for patients with aortic stenosis. 

Material and Methods

Patients

The study was of a cohort nature. The study group included 34 patients with stenosis of the aortic valve, who were planned for surgical intervention – prosthetics of this valve. The inclusion criteria were male sex (to exclude gender differences) and age over 18 years. The exclusion criteria were coronary heart disease, heart rate abnormalities (atrial fibrillation, frequent extrasystole, etc.) impeding the analysis of PPGV, endocrine disorders, peripheral microcirculation disorders, chronic gastrointestinal diseases (hepatitis, gastric ulcer, duodenum disease, and cholecystitis), chronic renal diseases and exacerbations of other chronic diseases, and obesity (body mass index more than 30 kg/m2). Adherence to inclusion and exclusion criteria was evaluated during clinical investigation.

The study derives from the clinical practice of the Bakulev Scientific Center for Cardiovascular Surgery (Moscow, Russia).

The control group included 30 healthy volunteers.

Detailed clinical characteristics of the groups are presented in Table 1.

Table 1: Clinical characteristics of the groups.

Estimate Patients with aortic stenosis (n=34) Healthy subjects

(n=30)

P-level
Age 54 (43, 67) 49 (43, 56) 0.656
Body mass index, kg/m2 28.0 (25.5, 30.4) 24.2 (22.8, 25.5) <0.001
BSA, m2 2.02 (1.95, 2.13) 1.92 (1.87, 2.16) 0.341
Prior myocardial infarction 0 0
Angina pectoris 0 0
Prior stroke 2 (5.9) 0 0.181
Prior atrial fibrillation 2 (5.9) 0 0.181
Hypertension 16 (47.1) 0 <0.001
Smoking 5 (14.7) 3 (10.0) 0.573
Diabetes 0 0
COPD 1 (2.9) 0 0.351
Creatinine, mg/dL 1.01 (0.89, 1.13) 0.78 (0.74, 0.81) 0.002
Prior PCI 0 0
Systolic blood pressure, mmHg 125 (120, 130) 120 (110, 125) 0.741
Diastolic blood pressure, mmHg 74 (70, 80) 75 (70, 80) 0.922
Blood glucose, mmol/L 5.3 (4.9, 5.7) 5.2 (4.8, 5.5) 0.425
White blood cells, 10*9/L 6.9 (5.7, 7.7) 6.8 (5.8, 7.9) 0.488
Hematocrit, % 42 (40, 44) 43 (41, 44) 0.812
EDV, ml 141 (112, 187) 123 (98, 133) <0.001
EDV / BSA, ml/m2 70.3 (58.0, 91.7) 67.8 (55.3, 77.6) 0.272
End-systolic volume, ml 47 (36, 62) 42 (34, 55) 0.214
End-systolic diameter, cm 3.5 (3.1, 3.9) 3.3 (2.8, 3.5) 0.021
EDD, cm 5.4 (5.0, 6.0) 4.6 (4.1, 5.0) <0.001
EDD / BSA, cm/m2 2.7 (2.4, 3.0) 2.5 (2.3, 3.1) 0.874
LVEF, % 63 (59, 68) 65 (61, 69) 0.612
ACE inhibitors 25 (73.5) 0 <0.001
Beta-blockers 22 (64.7) 0 <0.001
Statins 8 (23.5) 0 0.006
Diuretics 27 (79.4) 0 <0.001
Calcium antagonists 3 (8.8) 0 0.101

Continuous variables are presented as median with lower and upper quartiles – Me (LQ, UQ). Binary variables are presented as frequencies and percentages – n (%).

BSA, body surface area; PCI, percutaneous coronary intervention; COPD, cronic obstructive pulmonary disease; EDV, end-diastolic volume; EDD, end-diastolic diameter; LVEF, left ventricular ejection fraction; ACE, angiotensin-converting enzyme.

Ethical approval

Design of this study was approved by the Ethics Committee of the Saratov State Medical University (Saratov, Russia) in 2019. Informed consent was obtained from all participants. All procedures performed in the studies involving human participants were in accordance with the ethical standards of the institutional research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.

Signal recording

The variability of blood filling in the distal blood stream was recorded using a photoplethysmographic sensor from the distal phalanx of the left first finger. Signal data registration for all subjects was carried out using a multichannel polyrecorder (electroencephalograph analyzer EEGA-21/26 “Encephalan-131-03”, model 10 with a set of standard sensors, NPKF “Medicom MTD”, Russia). All signals were sampled at 250 samples per second and digitized at 14 bits. The time of the signal recording was always the same – morning hours (8.00-11.00), which excluded the influence of daily fluctuations in the autonomic regulation of the cardiovascular system. The recording was performed in a horizontal position of the subject. The duration of each recording was 5 minutes. Before the recording, the subjects were in a horizontal position, at rest for 10 minutes. 

Signal processing

The power spectra of PPGV were calculated directly from the photoplethysmographic signal based on a technique similar to our previous work (see “Signal processing” section in [15]). We calculated for these spectra the following spectral estimates of PPGV: LF% (low-frequency band, 0.04–0.15 Hz, in the percentage of total spectral power, 0–0.4 Hz), HF% (high-frequency band, 0.15– 0.4 Hz, in the percentage of total spectral power, 0–0.4 Hz), and LF/HF ratio. 

Statistical analysis

Continuous variables are reported as medians with lower and upper quartiles – Me (LQ, UQ). Binary variables are presented as frequencies and percentages – n (%). We applied the Shapiro–Wilk test to check whether the values were normally distributed. Since most variables were not normally distributed, further analysis was carried out using non-parametric statistical methods. We used the Mann–Whitney test to compare the values of continuous variables between the subjects’ groups. We applied the Chi-square (χ2) test to compare the binary variables and to compute the significance level for the difference between two proportions. The results were considered statistically significant if the p-value was less than 0.05.

Results

The study revealed the statistically significant (p<0.05) differences in values among two parameters (HF% and LF%) in patients with aortic valve disease compared with healthy people. The relative values (LF%) of low-frequency oscillations were increased by 2-4 times in group of patients with aortic stenosis, while the contribution of relative high-frequency (HF%) oscillations increased by 1.2-7 times. The interquartile range of the values of the LF/HF index was larger in healthy group, but the differences between the groups were statistically insignificant (Table 2).

Table 2: Comparison of spectral estimates of photoplethysmographic waveform variability between the groups.

Estimates Patients with aortic stenosis (n=34) Healthy subjects (n=30) p-level
HF% 52 (30, 66) 22 (4, 61) 0.019
LF% 38 (22, 53) 13 (5, 29) <0.001
LF/HF% 0.7 (0.4, 1.8) 0.6 (0.2, 4.8) 0.639

Discussion

According to our study, in patients with stenosis of the aortic valve requiring surgical correction, the contribution of low-frequency oscillations (to a greater extent characterizing sympathetic effects on peripheral vascular resistance [16]) and high-frequency oscillations (associated to a greater extent with respiratory effects [17]) in the distribution of the relative values ​​of spectral components of PPGV is increased. These changes accordingly affect the LF/HF index.

It is known that the dynamics of heart damage in case of aortic valve stenosis include several stages. The stage 1 includes an increase in the mass of the left ventricular myocardium, an increase in the filling pressure of the left ventricle, and systolic dysfunction, defined as a decrease in ejection fraction <50% [18]. Further, the pathological process is aggravated by damage to the left atrium and mitral valve (stage 2) [19], the involvement of the pulmonary vascular system and tricuspid valve (stage 3) [20], and damage to the right ventricle (stage 4) [21]. In other words, the forced intensified mechanical work of the heart leads to the formation and growth of concentric hypertrophy of the left ventricular myocardium [22], as a result of which the effective operation of the Frank-Starling mechanism supporting systemic hemodynamics is possible. Nevertheless, there is evidence that in patients with aortic stenosis and severe compensatory myocardial hypertrophy, the left ventricular ejection fraction is significantly reduced [23]. As a result, the reflex regulation of the heart’s activity changes, the sympathoadrenal system is activated and catecholamines are released leading to an increase in the heart rate. Because of this, the period of diastolic filling of the left ventricle is significantly decreased, increasing the already reduced cardiac output, the total peripheral vascular resistance rises even more, and tissue perfusion decreases [24, 25].

According to the literature, the work of the respiratory and vasomotor centres is closely related to each other. Fundamental experimental studies show that respiratory and autonomic nerve rhythms originate in the same region of the brain stem or are controlled by a common centre [26, 27]. This is evidenced by data on the dynamic relationship between the phases of breathing and the activity of the autonomic nervous system: an increase in the activity of the muscular sympathetic nerve at the end of expiration and a decrease at the end of inspiration [28], with a simultaneous increase in diastolic pressure in this phase [29].

As noted earlier, a decrease in the left ventricular ejection fraction with a compensatory increase in the activity of the sympathetic part of the nervous system is observed with aortic valve stenosis. Taken together, it leads to circulatory failure in the systemic circulation and a decrease in tissue perfusion [22]. In turn, hypoxia leads to an increase in the concentration in the blood of lipid peroxidation products, hydrogen ions, etc. This creates the prerequisites for the formation of metabolic acidosis and irritation of chemoreceptors. Along with this, the progression of aortic valve defect leads to the fact that the right heart is also involved in the pathological process (stages 3 and 4). It leads to an increase in pressure in the pulmonary circulation and overstretching of the mechanoreceptors of the right atrium and pulmonary arteries [30]. Afferentation from both chemo- and mechanoreceptors initiates the work of the respiratory centre aimed at maintaining homeostasis [31].

We assume that a significant increase in the relative values ​​of the contribution of low-frequency oscillations (estimated as LF%) supports the known fact of an increase in sympathetic influences on peripheral vascular resistance in aortic stenosis. Along with this, a significant increase in the relative values ​​of the contribution of high-frequency (respiratory) oscillations (estimated as HF%) is possible due to an increase in the functional activity of the respiratory centre.

In our previous work [15], we studied two groups of patients with other cardiovascular disease (hypertensive patients, and patients with stable coronary artery disease) of the same age as the group of patients with aortic stenosis. Patients with stenosis from current study gave higher LF% values ​​from both groups of these patients. Also, the HF% values ​​in the patients of this study are comparable to the values ​​of patients with hypertension from our previous work.

A limitation of our study is the stable drug therapy in all patients with aortic stenosis at the time of testing (see Table 1). It was part of the preoperative preparation and could influence the results of the study of autonomic regulation of blood circulation.

Conclusion

Patients with aortic stenosis are characterized by higher LF% and HF% values, relative to healthy people of comparable age. We consider that the use of PPGV spectral estimates has prospects for the development of new diagnostic methods in cardiology.

Conflict of Interest

Anton R. Kiselev was supported by the Grant of the President of the Russian Federation, МD-418.2019.7. Other authors declare no potential conflict of interest.

Funding Sources

The study was carried out in the framework of the scientific work “Development of a technology for screening health status based on the assessment of nonlinear biophysical properties of blood circulation regulation processes for the primary prevention of chronic cardiovascular diseases”, carried out at the Saratov State Medical University in accordance with the state task of the Ministry of Health of Russia for 2019-2021, (development of the method) and was supported by the Grant of the President of Russian Federation (project МD-418.2019.7) (registration, preliminary analysis and processing of experimental data, spectral analysis).

References

  1. Iung B, Baron G, Butchart EG, Delahaye F, Gohlke-Bärwolf C, Levang OW, et al. A prospective survey of patients with valvular heart disease in Europe: the Euro Heart Survey on Valvular Heart Disease. Eur Heart J 2003; 24: 1231–43.
    CrossRef
  2. Baumgartner H, Falk V, Bax JJ, De Bonis M, Hamm C, Holm PJ, et al. 2017 ESC/EACTS Guidelines for the management of valvular heart disease. Eur Heart J 2017; 38: 2739–91.
    CrossRef
  3. Borer JS, Bonow RO. Contemporary approach to aortic and mitral regurgitation. Circulation 2003; 108: 2432–8.
    CrossRef
  4. Ispiryan АYu, Simonyan МА, Kiselev АR. Heart rate variability in aortic valve defects. Annali Aritmologii 2019; 16(1): 36-41.
    CrossRef
  5. Heart rate variability: standards of measurement, physiological interpretation, and clinical use. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Circulation 1996; 93: 1043–65.
  6. Moraes JL, Rocha MX, Vasconcelos GG, Vasconcelos Filho JE, de Albuquerque VHC, Alexandria AR. Advances in photopletysmography signal analysis for biomedical applications. Sensors (Basel) 2018; 18: 1894.
    CrossRef
  7. Mörner S1, Wiklund U, Rask P, Olofsson BO, Kazzam E, Waldenström A. Parasympathetic dysfunction in hypertrophic cardiomyopathy assessed by heart rate variability: comparison between short-term and 24-h measurements. Clin Physiol Funct Imaging 2005; 25: 90-9.
    CrossRef
  8. Schwartz PJ, La Rovere MT, Vanoli E. Autonomic nervous system and sudden cardiac death. Experimental basis and clinical observations for post-myocardial infarction risk stratification. Circulation 1992; 85: I77-91.
  9. Ozdemir O1, Alyan O, Kacmaz F, Kaptan Z, Ozbakir C, Geyik B, et al. Evaluation of effects of intra aortic balloon counterpulsation on autonomic nervous system functions by heart rate variability analysis. Ann Noninvasive Electrocardiol 2007; 12: 38-43.
    CrossRef
  10. Kalisnik JM1, Avbelj V, Trobec R, Ivaskovic D, Vidmar G, Troise G, et al. Assessment of cardiac autonomic regulation and ventricular repolarization after off-pump coronary artery bypass grafting. Heart Surg Forum 2006; 9: E661-7. DOI: 10.1532/HSF98.2006-1020.
    CrossRef
  11. Anfinsen OG1, Aass H, Amlie JP. Heart rate variability. Parameters for risk stratification after myocardial infarction. Tidsskr Nor Laegeforen 1997; 117: 376-80.
  12. Balanescu S, Corlan AD, Dorobantu M, Gherasim L. Prognostic value of heart rate variability after acute myocardial infarction. Med Sci Monit 2004; 10: CR307-15.
  13. Villareal RP, Liu BC, Massumi A. Heart rate variability and cardiovascular mortality. Curr Atheroscler Rep 2002; 4: 120-7.
    CrossRef
  14. Ewing Heart rate variability: an important new risk factor in patients following myocardial infarction. Clin Cardiol 1991; 14: 683-5.
    CrossRef
  15. Kiselev AR, Karavaev The intensity of oscillations of the photoplethysmographic waveform variability at frequencies 0.04-0.4 Hz is effective marker of hypertension and coronary artery disease in males. Blood Pressure 2020; 29: 55-62.
    CrossRef
  16. Middleton PM, Chan GS, Steel E, et al. Fingertip photoplethysmographic waveform variability and systemic vascular resistance in intensive care unit patients. Med Biol Eng Comput 2011; 49: 859–66.
    CrossRef
  17. Bernardi L, Radaelli A, Solda PL, et al. Autonomic control of skin microvessels: assessment by power spectrum of photoplethysmographic waves. Clin Sci 1996; 90: 345–55.
    CrossRef
  18. Lang RM, Badano LP, Mor-Avi V, et.al. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr 2015; 28: 1–39.e14.
    CrossRef
  19. Nagueh SF, Smiseth OA, Appleton CP, et al. Recommendations for the evaluation of left ventricular diastolic function by echocardiography: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr 2016; 29: 277–314.
    CrossRef
  20. Lindman BR, Maniar HS, Jaber WA, et al. Effect of tricuspid regurgitation and the right heart on survival after transcatheter aortic valve replacement: insights from the placement of aortic transcatheter valves II inoperable cohort. Circ Cardiovasc Interv 2015; 8:e002073.
    CrossRef
  21. Genereux P, Pibarot P, Redfors B, et al. Staging classification of aortic stenosis based on the extent of cardiac damage. Eur Heart J 2017; 38: 3351–8.
    CrossRef
  22. Krayenbuehl HP, Hess OM, Ritter M, Monrad ES, Hoppeler H. Left ventricular systolic function in aortic stenosis. Eur Heart J 1988; 9 Suppl. E: 19–23.
    CrossRef
  23. Krayenbuehl HP, Hess OM, Schneider J, Turina M. Left ventricular function and myocardial structure in aortic valve disease before and after surgery. Herz 1984; 9: 270–8.
  24. Floras JS. Clinical aspects of sympathetic activation and parasympathetic withdrawal in heart failure. J Am Coll Cardiol 1993; 22(4 Suppl. A): 72A–84A.
    CrossRef
  25. Charkoudian N, Joyner MJ, Johnson CP, Eisenach JH, Dietz NM, Wallin BG. Balance between cardiac output and sympathetic nerve activity in resting humans: role in arterial pressure regulation. J Physiol 2005; 568: 315–21.
    CrossRef
  26. Bachoo M, Polosa C. Properties of the inspiration-related activity of sympathetic preganglionic neurones of the cervical trunk in the cat. J Physiol 1987; 385: 545–64.
    CrossRef
  27. Guyenet PG, Dernall RA, Riley TA. Rostral ventrolateral medulla and sympathorespiratory integration in rats. Am J Physiol 1990; 259: R1063–74.
    CrossRef
  28. Eckberg DL. The human respiratory gate. J Physiol 2003; 584: 339–52.
    CrossRef
  29. Michard F. Changes in arterial pressure during mechanical ventilation. Anesthesiology 2005; 103: 419-28.
    CrossRef
  30. Triedman J, Saul J. Blood pressure modulation by central venous pressure and respiration. Buffering effects of the heart rate reflexes. Circulation 1994; 89: 169–79.
    CrossRef
  31. Tkachenko VL, Levtov VA. Principles of regulation of blood circulation. In: Regulyatsiya Krovoobrashecheniya (Regulation of Blood Circulation). Leningrad, USSR: Nauka, 1986: 5.
Share Button
Visited 444 times, 1 visit(s) today

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.